Clearview Wealth Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,614
Closed -$404K 98
2024
Q1
$404K Sell
3,614
-4,263
-54% -$460K 0.41% 59
2023
Q4
$794K Buy
+7,877
New +$782K 0.93% 36
2023
Q3
Sell
-397
Closed -$37.5K 187
2023
Q2
$37.5K Buy
397
+3
+0.8% +$253 0.04% 211
2023
Q1
$29.8K Sell
394
-7
-2% -$528 0.03% 231
2022
Q4
$30.9K Buy
401
+13
+3% +$988 0.02% 200
2022
Q3
$26K Buy
388
+3
+0.8% +$190 0.02% 222
2022
Q2
$20K Buy
385
+3
+0.8% +$171 0.02% 275
2022
Q1
$22K Buy
382
+4
+1% +$214 0.01% 287
2021
Q4
$20K Buy
378
+3
+0.8% +$147 0.01% 330
2021
Q3
$19K Buy
+375
New +$20.3K 0.01% 341
2021
Q2
Sell
-380
Closed -$23K 648
2021
Q1
$23K Buy
380
+180
+90% +$9.94K 0.01% 315
2020
Q4
$11K Buy
+200
New +$10.4K 0.01% 360

Other funds holding CAH

Clearview Wealth Advisors's CAH Position: Q2 2024 in Review

Clearview Wealth Advisors sold out of Cardinal Health (CAH) in Q2 2024, closing a stake of 3,614 shares — an estimated $404K sold.

Clearview Wealth Advisors first reported a position in CAH in Q4 2020 and held it in 12 quarters. The position peaked at $794K in Q4 2023. 1,009 funds tracked by Wall St. Rank hold CAH as of Q2 2024.

  • Clearview Wealth Advisors reported no remaining Cardinal Health position as of Q2 2024 after selling out during the quarter.
  • Clearview Wealth Advisors sold 3,614 Cardinal Health shares in Q2 2024, an estimated $404K.
  • Clearview Wealth Advisors first reported a position in Cardinal Health in Q4 2020 and held it in 12 quarters.
  • Clearview Wealth Advisors's Cardinal Health position peaked at $794K in Q4 2023.
  • 1,009 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2024.

Based on Clearview Wealth Advisors's 13F filing for Q2 2024, filed 1 Aug 2024.